Related Experiment Video

Updated: Jun 1, 2026

Detection of Targetable Alterations in Non-small Cell Lung Cancer using Next-generation Sequencing
05:17

Detection of Targetable Alterations in Non-small Cell Lung Cancer using Next-generation Sequencing

Published on: October 10, 2025

[Study on point mutations of K-ras gene in non-small cell lung cancer in Guangxi]

Weixiang Zhong1, Mingwu Chen, Lei Xian

  • 1Department of Cardiothoracic Surgery, the First Affiliated Hospital of Guangxi Medical University, Nanning 530021, China.

Zhongguo Fei AI Za Zhi = Chinese Journal of Lung Cancer
|June 8, 2011
PubMed
Abstract

Insights

In Guangxi, non-small cell lung cancer (NSCLC) patients rarely have K-ras gene mutations. This suggests that most NSCLC patients in this region may benefit from epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI) therapy.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • K-ras mutations in non-small cell lung cancer (NSCLC) are linked to resistance to epidermal growth factor receptor-tyrosine kinase inhibitors (EGFR-TKIs).
  • Understanding K-ras mutation status is crucial for guiding NSCLC treatment strategies.

Purpose of the Study:

  • To investigate the prevalence of K-ras gene mutations in NSCLC patients in the Guangxi region.
  • Specifically, to detect point mutations in codons 12, 13, and 61 of the K-ras gene.

Main Methods:

  • Analysis of 105 NSCLC tissue samples and 30 adjacent normal tissues.
  • Polymerase chain reaction (PCR) amplification followed by single-strand conformation polymorphism (SSCP) and DNA sequencing.

Main Results:

  • No K-ras gene mutations were detected in codons 12, 13, or 61 in any of the 105 NSCLC samples.
  • The mutation frequency of the K-ras gene in this NSCLC cohort was 0%.

Conclusions:

  • The high frequency of wild-type K-ras genes in NSCLC patients from Guangxi suggests potential therapeutic benefits from EGFR-TKIs.
  • This finding supports the use of EGFR-TKI therapy for NSCLC patients in Guangxi, as they are less likely to exhibit resistance due to K-ras mutations.

Related Concept Videos

The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
Small GTPases - Ras and Rho01:24

Small GTPases - Ras and Rho

Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
Single Nucleotide Polymorphisms-SNPs01:05

Single Nucleotide Polymorphisms-SNPs

A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...